Dawn A. Brooks

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Studies of mild dehydrogenations in heterocyclic systems

David R. Williams, Patrick D. Lowder, Yu-Gui Gu et al. · Tetrahedron Letters · 1997 · 196 citations

Natural Sciences, Chemistry, Physical Chemistry +8

Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes

Sergey Shcherbinin, Cynthia Evans, Ming‐Chi Lu et al. · JAMA Neurology · 2022 · 188 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease

Jennifer A. Zimmer, Paul Ardayfio, Hong Wang et al. · JAMA Neurology · 2025 · 117 citations · Full text

Medicine, Neurology, Neuroscience +17

A Tailored Therapy for the Metabolic Syndrome

Garret J. Etgen, Brian A. Oldham, W. Thomas Johnson et al. · Diabetes · 2002 · 105 citations · Full text

Medicine, Endocrinology, Pharmacology +17